BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17218420)

  • 1. Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.
    Wu SV; Yuan PQ; Wang L; Peng YL; Chen CY; Taché Y
    Endocrinology; 2007 Apr; 148(4):1675-87. PubMed ID: 17218420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.
    Yuan PQ; Wu SV; Pothoulakis C; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G387-98. PubMed ID: 26744472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
    Tasma Z; Wills P; Hay DL; Walker CS
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
    Kageyama K; Gaudriault GE; Suda T; Vale WW
    Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
    Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
    Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
    Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cells.
    Nemoto T; Mano-Otagiri A; Shibasaki T
    Biochem Biophys Res Commun; 2005 May; 330(3):821-31. PubMed ID: 15809070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
    Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional CRF receptors in BON cells stimulate serotonin release.
    von Mentzer B; Murata Y; Ahlstedt I; Lindström E; Martínez V
    Biochem Pharmacol; 2007 Mar; 73(6):805-13. PubMed ID: 17184738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
    Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.